BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.

Inclusion Criteria: * Age: 19\~45 * Body weight: 55kg or higher(female: 50kg or higher) and BMI 18\~27kg/m2 * SBP 90\~150mmHg, DBP 60-95mmHg * Fasting glucose 70\~120mg/dL * Infertility 1. Surgically infertile 2. To prevent pregnancy, participants who agreed using 2 or more contraceptive methods. Such as * Barrier methods: Condom, Diaphragm, Cervical cap (Pessary), Spermicide * Hormonal methods: Pills, Injection (Depot), Skin patch, Hormonal implant (Implanon), Vaginal ring * Intrauterine Devices (IUDs): Cooper IUD (Loop), Hormonal IUD (Mirena) * Natural methods: Basic body temperature, Ovulation period, Coitus interruptus, Abstinent * People who perfectly understood clinical trial and independently decided to participate in clinical trial. * People who will be able to collect blood sample during clinical trial period. * People who are suitable to participate clinical trial by physical examination, lab test and medical examination by interview. Exclusion Criteria: * Genetic problems such as galactose intolerance, Lapp lacatase deficiency, glucose-galactose malabsorption * Clinically significant disease such as liver, kidney, digestive, pulmonary, endocrine system, cardiovascular disease etc. * People who have gastrointestinal disease or history of surgery which would affect absorption of drug. * History of clinically significant drug induced hyper-sensitive reaction or drug related muscular disease